4-cyclohexyl-3-{[(3-methoxyphenyl)amino]methyl}-4,5-dihydro-1H-1,2,4-triazole-5-thione, 100mg

7-IODO-1H-INDAZOLE, 95%, 500mg

trans-cinnamaldéhyde, min 98,5%, pour la synthèse, 250 ml, emballage en verre

N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 95.0%, 10g

Isoquinoline, 6-bromo-1-chloro-7-methoxy-, 98%, 500mg

Methyl 3,6-dibromopyrazine-2-carboxylate, 95.0%, 5g

Imidazole Hydrobromide (Low water content)>98.0%(HPLC)(T)1g

3,4-Dimethylpentanoic acid, 98%, 50mg

10-(4-Bromophenyl)-9,9-dimethyl-9,10-dihydroacridine, 97%, 10g

7-(TERT-BUTOXYCARBONYL)-2-OXA-7-AZASPIRO[4.5]DECANE-3-CARBOXYLIC ACID, 95.0%, 25mg

2-Chloro-6-phenylpyrazine, 95.0%, 1g

2-(4-Bromo-2-fluoro-5-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

1-(2-phenoxyethyl)hydrazine hydrochloride, 95.0%, 250mg